RT Book, Section
A1 Menasché, Philippe
A2 Cohn, Lawrence H.
SR Print(0)
ID 55931349
T1 Chapter 70. Stem Cell–Induced Regeneration of Myocardium
T2 Cardiac Surgery in the Adult, 4e
YR 2012
FD 2012
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-163310-9
LK accesssurgery.mhmedical.com/content.aspx?aid=55931349
RD 2024/04/19
AB Statistics  recently  published  by  the  American  Heart  Association  clearly  outline  the  magnitude  of  the  medical  and  economic  problems  associated  with  heart  failure.1  It  is  estimated  that  6  million  people  in  the  United  States  are  affected  by  this  disease,  with  a  yearly  incidence  of  new  episodes  (per  1000  people)  of  15.2  between  65  and  74  years  of  age,  a  figure  that  is  two  times  higher  between  75  and  84  years  of  age.  Still  in  the  United  States,  the  number  of  hospitalizations  for  heart  failure  has  thus  increased  from  877,000  to  1,106,000  in  a  10-year  time  frame  (1996–2006),  but  the  problem  is  now  worldwide.  The  mortality  remains  high  as  80%  of  men  and  70%  of  women  under  the  age  of  65  years  in  whom  heart  failure  has  been  diagnosed  are  expected  to  die  within  the  next  8  years  with  a  risk  of  sudden  death  which  is  six  to  nine  times  that  of  the  general  population.  As  expected,  these  figures  translate  into  a  heavy  economic  burden  with  costs  estimated  to  37  billion  dollars  in  2008.